ES2190130T3 - Uretanos derivados de azacicloalcanos, sus analogos tio y ditio, su preparacion y su empleo como inhibidores de 2,3-epoxiescualeno-lanosterol-ciclasa. - Google Patents
Uretanos derivados de azacicloalcanos, sus analogos tio y ditio, su preparacion y su empleo como inhibidores de 2,3-epoxiescualeno-lanosterol-ciclasa.Info
- Publication number
- ES2190130T3 ES2190130T3 ES98962423T ES98962423T ES2190130T3 ES 2190130 T3 ES2190130 T3 ES 2190130T3 ES 98962423 T ES98962423 T ES 98962423T ES 98962423 T ES98962423 T ES 98962423T ES 2190130 T3 ES2190130 T3 ES 2190130T3
- Authority
- ES
- Spain
- Prior art keywords
- group
- atom
- alkyl
- bond
- nitrogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000003112 inhibitor Substances 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 4
- 229910052717 sulfur Inorganic materials 0.000 abstract 3
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 2
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 abstract 2
- 125000003342 alkenyl group Chemical group 0.000 abstract 2
- 125000000304 alkynyl group Chemical group 0.000 abstract 2
- 125000005843 halogen group Chemical group 0.000 abstract 2
- 229910052757 nitrogen Inorganic materials 0.000 abstract 2
- 229910052760 oxygen Inorganic materials 0.000 abstract 2
- 239000001301 oxygen Substances 0.000 abstract 2
- 125000004434 sulfur atom Chemical group 0.000 abstract 2
- 125000003341 7 membered heterocyclic group Chemical group 0.000 abstract 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 abstract 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 abstract 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- XOCUXOWLYLLJLV-UHFFFAOYSA-N [O].[S] Chemical group [O].[S] XOCUXOWLYLLJLV-UHFFFAOYSA-N 0.000 abstract 1
- 125000004450 alkenylene group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 125000004419 alkynylene group Chemical group 0.000 abstract 1
- 125000004429 atom Chemical group 0.000 abstract 1
- 150000003976 azacycloalkanes Chemical class 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 239000011203 carbon fibre reinforced carbon Substances 0.000 abstract 1
- 229910052801 chlorine Inorganic materials 0.000 abstract 1
- 239000000460 chlorine Substances 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 229910052731 fluorine Inorganic materials 0.000 abstract 1
- 239000011737 fluorine Substances 0.000 abstract 1
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 abstract 1
- -1 methylene, carbonyl Chemical group 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 125000001624 naphthyl group Chemical group 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229920006395 saturated elastomer Polymers 0.000 abstract 1
- 125000000475 sulfinyl group Chemical group [*:2]S([*:1])=O 0.000 abstract 1
- 239000011593 sulfur Substances 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
- 150000003673 urethanes Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/116—Heterocyclic compounds
- A23K20/132—Heterocyclic compounds containing only one nitrogen as hetero atom
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
- A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/54—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
- C07D211/64—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having an aryl radical as the second substituent in position 4
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Cardiology (AREA)
- Birds (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Heart & Thoracic Surgery (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Urology & Nephrology (AREA)
- Obesity (AREA)
- Oncology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Fodder In General (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Steroid Compounds (AREA)
Abstract
Uretanos derivados de azacicloalcanos, así como a sus análogos tio y ditio de la fórmula general en la que **(Fórmula)** m significa los números 0 ó 1, n significa los números 1 ó 2, A significa un enlace sencillo, un grupo alquileno C1_8 de cadena lineal o ramificada, un grupo alquenileno C2-8 o alquinileno C2-8, no estando un grupo insaturado directamente unido al radical Y, X significa un átomo de oxígeno o azufre, Y significa un átomo de oxígeno a azufre, R1 significa un grupo alquilo C1-6 de cadena lineal o ramificada, un grupo alquenilo C1-4 o un grupo alquinilo C1-4, estando aislado el enlace múltiple del enlace nitrógeno-carbono, R2 significa un grupo alquilo C1-6 de cadena lineal o ramificada, un grupo alquenilo C1-4 o un grupo alquinilo C1-4, estando aislado un enlace múltiple del enlace nitrógeno-carbono, o R1 y R2, junto con el átomo de nitrógeno, significan un anillo heterocíclico saturado de 5 a 7 miembros, en el que un grupo metileno aislado del átomo de nitrógeno puede estarreemplazado por un átomo de oxígeno o azufre o por un grupo -NH o -N(alquilo), R3 a R6, que pueden ser iguales o diferentes, significan átomos de hidrógeno o grupos alquilo, R7 significa un grupo cicloalquilo C3-7, un grupo fenilo o naftilo eventualmente sustituido con uno o dos átomos de halógeno, con un grupo alquilo, alcoxi, trifluorometilo o ciano o, si A no representa un enlace sencillo, significa también un átomo de hidrógeno, E significa un átomo de oxígeno o azufre, un grupo metileno, carbonilo o sulfinilo y R8 significa un átomo de hidrógeno, o E significa el grupo -C(R9R10)-, en donde R9 representa un átomo de hidrógeno y R10, junto con el grupo R8 contiguo, representa un enlace carbono-carbono, en donde, si no se ha mencionado otra cosa, los grupos alquilo contenidos en los radicales precedentemente mencionados pueden contener en cada caso de 1 a 3 átomos de carbono y un átomo de halógeno precedentemente mencionado puede significar un átomo de flúor, cloro o bromo, sus enantiómeros, diastereoisómeros, sus mezclas y sus sales.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19754796A DE19754796A1 (de) | 1997-12-10 | 1997-12-10 | Neue, von Azacycloalkanen abgeleitete Urethane, ihre Thio- und Dithioanaloga, deren Salze, diese Verbindungen enthaltende Arzneimittel und deren Verwendung sowie Verfahren zu ihrer Herstellung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2190130T3 true ES2190130T3 (es) | 2003-07-16 |
Family
ID=7851381
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES98962423T Expired - Lifetime ES2190130T3 (es) | 1997-12-10 | 1998-12-08 | Uretanos derivados de azacicloalcanos, sus analogos tio y ditio, su preparacion y su empleo como inhibidores de 2,3-epoxiescualeno-lanosterol-ciclasa. |
Country Status (27)
| Country | Link |
|---|---|
| EP (1) | EP1060162B1 (es) |
| JP (1) | JP3418688B2 (es) |
| KR (1) | KR20010032977A (es) |
| CN (1) | CN1281434A (es) |
| AR (1) | AR017827A1 (es) |
| AT (1) | ATE234816T1 (es) |
| AU (1) | AU1759499A (es) |
| BG (1) | BG104500A (es) |
| BR (1) | BR9813495A (es) |
| CA (1) | CA2309388A1 (es) |
| CO (1) | CO5370694A1 (es) |
| DE (2) | DE19754796A1 (es) |
| DK (1) | DK1060162T3 (es) |
| EA (1) | EA200000631A1 (es) |
| EE (1) | EE200000342A (es) |
| ES (1) | ES2190130T3 (es) |
| HR (1) | HRP20000377A2 (es) |
| HU (1) | HUP0100335A3 (es) |
| IL (1) | IL135738A0 (es) |
| NO (1) | NO20002967L (es) |
| PL (1) | PL341060A1 (es) |
| PT (1) | PT1060162E (es) |
| SK (1) | SK8612000A3 (es) |
| TR (1) | TR200001635T2 (es) |
| WO (1) | WO1999029669A1 (es) |
| YU (1) | YU35600A (es) |
| ZA (1) | ZA9811262B (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040072865A1 (en) * | 2001-01-15 | 2004-04-15 | Bouillot Anne Marie Jeanne | Aryl piperidine derivatives as inducers of ldl-receptor expression |
| JP2004520347A (ja) * | 2001-01-15 | 2004-07-08 | グラクソ グループ リミテッド | Ｌｄｌ−受容体発現のインデューサーとしてのアリールピペリジンおよびピペラジン誘導体 |
| EP1351937A1 (en) * | 2001-01-15 | 2003-10-15 | Glaxo Group Limited | Aryl piperidine derivatives as inducers of ldl-receptor expression |
| DE10132686A1 (de) * | 2001-07-05 | 2003-01-16 | Boehringer Ingelheim Pharma | Heteroarylcarbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel |
| JP4664634B2 (ja) * | 2003-09-05 | 2011-04-06 | 富山化学工業株式会社 | 新規なベンズアミジン誘導体またはその塩 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH04312572A (ja) * | 1991-04-12 | 1992-11-04 | Takeda Chem Ind Ltd | 環状アミン化合物 |
| DE4407138A1 (de) | 1994-03-04 | 1995-09-07 | Thomae Gmbh Dr K | Aryliden-1-azacycloalkane und Arylalkyl-1-azacycloalkane, deren Salze, diese Verbindungen enthaltende Arzneimittel und deren Verwendung sowie Verfahren zu ihrer Herstellung |
| DE4407136A1 (de) | 1994-03-04 | 1995-09-07 | Thomae Gmbh Dr K | Aroyl-1-azacycloalkane, deren Salze, diese Verbindungen enthaltende Arzneimittel und deren Verwendung sowie Verfahren zu ihrer Herstellung |
-
1997
- 1997-12-10 DE DE19754796A patent/DE19754796A1/de not_active Withdrawn
-
1998
- 1998-12-08 ES ES98962423T patent/ES2190130T3/es not_active Expired - Lifetime
- 1998-12-08 CN CN98811959A patent/CN1281434A/zh active Pending
- 1998-12-08 TR TR2000/01635T patent/TR200001635T2/xx unknown
- 1998-12-08 KR KR1020007006326A patent/KR20010032977A/ko not_active Withdrawn
- 1998-12-08 BR BR9813495-7A patent/BR9813495A/pt not_active IP Right Cessation
- 1998-12-08 HR HR20000377A patent/HRP20000377A2/hr not_active Application Discontinuation
- 1998-12-08 PT PT98962423T patent/PT1060162E/pt unknown
- 1998-12-08 IL IL13573898A patent/IL135738A0/xx unknown
- 1998-12-08 AU AU17594/99A patent/AU1759499A/en not_active Abandoned
- 1998-12-08 HU HU0100335A patent/HUP0100335A3/hu unknown
- 1998-12-08 AT AT98962423T patent/ATE234816T1/de not_active IP Right Cessation
- 1998-12-08 PL PL98341060A patent/PL341060A1/xx unknown
- 1998-12-08 EE EEP200000342A patent/EE200000342A/xx unknown
- 1998-12-08 EP EP98962423A patent/EP1060162B1/de not_active Expired - Lifetime
- 1998-12-08 CA CA002309388A patent/CA2309388A1/en not_active Abandoned
- 1998-12-08 DE DE59807591T patent/DE59807591D1/de not_active Expired - Fee Related
- 1998-12-08 SK SK861-2000A patent/SK8612000A3/sk unknown
- 1998-12-08 DK DK98962423T patent/DK1060162T3/da active
- 1998-12-08 EA EA200000631A patent/EA200000631A1/ru unknown
- 1998-12-08 WO PCT/EP1998/007965 patent/WO1999029669A1/de not_active Ceased
- 1998-12-08 YU YU35600A patent/YU35600A/sh unknown
- 1998-12-08 JP JP2000524266A patent/JP3418688B2/ja not_active Expired - Fee Related
- 1998-12-09 CO CO98073126A patent/CO5370694A1/es not_active Application Discontinuation
- 1998-12-09 ZA ZA9811262A patent/ZA9811262B/xx unknown
- 1998-12-09 AR ARP980106228A patent/AR017827A1/es not_active Application Discontinuation
-
2000
- 2000-06-02 BG BG104500A patent/BG104500A/bg unknown
- 2000-06-09 NO NO20002967A patent/NO20002967L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0100335A3 (en) | 2001-11-28 |
| EP1060162A1 (de) | 2000-12-20 |
| BR9813495A (pt) | 2000-10-10 |
| DE19754796A1 (de) | 1999-06-17 |
| CN1281434A (zh) | 2001-01-24 |
| DK1060162T3 (da) | 2003-07-14 |
| HUP0100335A2 (hu) | 2001-07-30 |
| JP2001525397A (ja) | 2001-12-11 |
| CO5370694A1 (es) | 2004-02-27 |
| WO1999029669A1 (de) | 1999-06-17 |
| KR20010032977A (ko) | 2001-04-25 |
| HRP20000377A2 (en) | 2000-12-31 |
| PL341060A1 (en) | 2001-03-26 |
| TR200001635T2 (tr) | 2000-11-21 |
| YU35600A (sh) | 2002-09-19 |
| PT1060162E (pt) | 2003-08-29 |
| DE59807591D1 (de) | 2003-04-24 |
| JP3418688B2 (ja) | 2003-06-23 |
| ZA9811262B (en) | 2000-06-09 |
| NO20002967D0 (no) | 2000-06-09 |
| NO20002967L (no) | 2000-08-09 |
| SK8612000A3 (en) | 2000-11-07 |
| AU1759499A (en) | 1999-06-28 |
| EE200000342A (et) | 2001-08-15 |
| BG104500A (bg) | 2001-03-30 |
| ATE234816T1 (de) | 2003-04-15 |
| AR017827A1 (es) | 2001-10-24 |
| EP1060162B1 (de) | 2003-03-19 |
| EA200000631A1 (ru) | 2000-12-25 |
| IL135738A0 (en) | 2001-05-20 |
| CA2309388A1 (en) | 1999-06-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO4520230A1 (es) | Derivados de [3-(4-fenilpiperacin-1-il) propilamino, tio y oxilo]-piridina, pirimidina y benceno como antagonistas de alfa 1- adrenoceptores | |
| AR020165A1 (es) | Derivados de pirimidinas sustituidas, su procedimiento de preparacion, composiciones farmaceuticas que las contienen y el uso de los mismos para la preparacion de medicamentos | |
| ES2220529T3 (es) | Dibenzopiranos utiles como antagonistas del receptor de los glucocorticoides, en el tratamiento de la diabetes. | |
| ES2258459T3 (es) | Pirrolotriazinas inhibidoras de quinasas. | |
| ES2189726T3 (es) | Isoxazolidinas sustituidas con heterociclo y su uso como fungicidas. | |
| GT200300135A (es) | Derivados de indolinfenilsulfonamida | |
| CO5680403A2 (es) | Antagonistas de mchr1r | |
| ES8600305A1 (es) | Procedimiento de preparar compuestos beta-lactamicos | |
| AR027611A1 (es) | 3-fenil-5-alcoxi-1,3,4-oxodiazol-2-onas substituidas, su produccion y empleo en substancias farmaceuticas | |
| AR013693A1 (es) | Nuevas piperidinas y piperazinas como inhibidores de la agregacion plaquetaria | |
| ES2142773B1 (es) | Derivados de mononitrato de isosorbida y su empleo como agentes vasodilatadores con tolerancia desminuida. | |
| HUP0002330A2 (hu) | Azetidinilpropilpiperidin-származékok, ezek intermedierjei és tachikinin antagonistaként történő alkalmazásuk | |
| ES2026669T3 (es) | Procedimiento para la preparacion y el uso terapeutico de los beta-d-fenil tioxilosidos. | |
| AR040140A1 (es) | Derivados de esteres de camptotecina en la posicion 20 | |
| AR040139A1 (es) | Camptotecinas con un anillo lactona modificado | |
| CO5370694A1 (es) | Nuevos uretanos derivados de azacicloalcanos, sus analogos tio y ditio, sus sales, medicamentos que contienen estos compuestos y su empleo asi como procedimientos para su preparacion | |
| ES2171306T3 (es) | Compuesto bajo la forma de isomero geometrico puro o de una mezcla de estos isomeros. | |
| ES2072095T3 (es) | Derivados de tiazolidinona y oxazolidinona, su preparacion y su uso como vasodilatadores. | |
| ES2328496T3 (es) | Compuestos de 1,4,8-triaza-espiro(4,5)decan-2-ona sustituidos. | |
| AR015311A1 (es) | Compuestos diaril selenuros, composiciones farmaceuticas y composiciones cosmeticas que comprenden al menos uno de dichos compuestos y utilizacion de la composicion cosmetica | |
| ES2105939B1 (es) | Nuevos pirazoles con actividad antagonista de la angiotensina ii. | |
| ECSP045200A (es) | Acidos 3-(imidazolil)-2-alcoxipropanoicos | |
| ES8706690A1 (es) | Un procedimiento para la preparacion de nuevos derivados de penem. | |
| CO5290251A1 (es) | Nuevos uretanos, analogos tio y ditio, sus sales, medicamen- tos que contienen estos compuestos y su empleo asi como pro- cedimientos para su preparacion | |
| ES2065992T3 (es) | Uso de derivados de imidazopirazol como analgesicos y agentes anti-inflamatorios. |